Relieves pain during labor, and -. ANDA 74626, held by Hospira. Butorphanol Tartrate.
As of Nov 16, 2026, ANDA 74626 (Butorphanol Tartrate Preservative Free), held by Hospira, was first approved by FDA on Jan 23, 1997, with 22 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Butorphanol Tartrate Injection is indicated - as a preoperative or pre-anesthetic medication - as a supplement to balanced anesthesia - for the relief of pain during labor, and - for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 23, 1997 | Original application | Approved | None posted |
| Butorphanol Tartrate Preservative Free1MG/ML · injectable;injection | Butorphanol Tartrate | Rx |
| Butorphanol Tartrate Preservative Free2MG/ML · injectable;injection | Butorphanol Tartrate | Rx |
| Sep 24, 2026 | Supplement 43Labeling · Standard review | Approved | None posted |
| Dec 22, 2025 | Supplement 42Labeling · Standard review | Approved | None posted |
| Apr 4, 2024 | Supplement 38Labeling · Standard review | Approved | None posted |
| Dec 19, 2023 | Supplement 35Labeling · Standard review | Approved | None posted |
| Oct 11, 2019 | Supplement 30Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 28Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 27Labeling · Standard review | Approved | None posted |
| May 8, 2003 | Supplement 13Labeling | Approved | None posted |
| Oct 25, 2002 | Supplement 14Manufacturing | Approved | None posted |
| Sep 18, 2002 | Supplement 15Labeling | Approved | None posted |
| Sep 7, 2001 | Supplement 12Manufacturing | Approved | None posted |
| Mar 22, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Mar 22, 2001 | Supplement 9Manufacturing | Approved | None posted |
| Feb 14, 2001 | Supplement 11Manufacturing | Approved | None posted |
| Mar 1, 2000 | Supplement 8Manufacturing | Approved | None posted |
| Mar 1, 2000 | Supplement 6Manufacturing | Approved | None posted |
| Mar 1, 2000 | Supplement 5Labeling | Approved | None posted |
| Mar 1, 2000 | Supplement 4Manufacturing | Approved | None posted |
| Jan 7, 2000 | Supplement 3Labeling | Approved | None posted |
| Jan 7, 2000 | Supplement 2Manufacturing | Approved | None posted |
| Oct 22, 1999 | Supplement 7Labeling | Approved | None posted |
| Nov 23, 1998 | Supplement 1Manufacturing | Approved | None posted |
| Jan 23, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters